• OPEN AN ACCOUNT
Indian Indices
Sensex
82,031.81 -500.38
( -0.61%)
Global Indices
Nasdaq
50,652.56 -976.61
(-1.89%)
Dow Jones
7,328.13 -109.46
(-1.47%)
Hang Seng
59,089.01 228.58
(0.39%)
Nikkei 225
10,703.23 -178.32
(-1.64%)
Forex
USD-INR
93.96 -0.30
(-0.32%)
EUR-INR
103.45 -0.43
(-0.42%)
GBP-INR
123.99 -0.51
(-0.41%)
JPY-INR
0.59 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
18.604918
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
40.12
77.09
EPS(TTM)
Face Value()
Div & Yield %
1.26
10
0
 

Mobavenue AI Tech appoints ikram Sheth as Chief of Corporate Development and Investor Relations
Oct 29,2026

Mobavenue AI Tech has appointed Vikram Sheth as Chief of Corporate Development and Investor Relations. In this role, he will lead corporate development, fundraising, strategic acquisitions and investor relations that will align with the company's long-term business priorities.

Vikram brings 30 years of experience, primarily in investment banking, with expertise in capital markets, mergers and acquisitions, fundraising and deal structuring. During his career, he has helped companies raise more than USD 3 billion in capital and advised large conglomerates and mid-market businesses across industries on fundraising, strategic transactions and business growth. Before joining Mobavenue, he was also a partner and Head of the investment banking practice at NAFA Group. He gained substantive experience with organizations such as ICICI Securities, Edelweiss and Religare, wherein he held leadership positions. Alongside his investment banking career, Vikram has contributed to management education as a visiting faculty and representing on the Board of Studies at several Mumbai-based institutions, including NMIMS.